News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Alexis Vandier has joined SERVIER as Global Asset leader for Vorasidenib
Photo: Alexis Vandier/LinkedIn
May 15, 2023, 11:51

Alexis Vandier has joined SERVIER as Global Asset leader for Vorasidenib

Thanks Katéri Cuvillier. I am very proud of joining Servier with an immediate focus on bringing new solution for patients with brain cancer. I have been lucky to meet great people at Servier and I feel privileged to join a global company with french roots which has been able to build such a great oncology franchise in very short time – Alexis Vandier

Source: Alexis Vandier/LinkedIn

Alexis Vandier Servier Vorasidenib
Special Coverage
Career
Jan 16, 2025, 12:30
OncoInfluencers to Follow on Social Media: Lisa Stevens
Dialogues
Jan 16, 2025, 12:30
The Need for Common Sense Oncology - Global Cancer Movement
Blog
Jan 16, 2025, 12:26
Eric K. Singhi: Moments like these remind me why I love what I do
Blog
Jan 16, 2025, 10:18
Elizabeth Ugwoma Awo-Ejeh: Lessons I Learned from My Breast Cancer Journey
Science
Jan 16, 2025, 10:17
Jason Sheehan: Preoperative versus postoperative SRS for brain metastasis
Blog
Jan 16, 2025, 10:13
Elizabeth McKenna: The January issue of Cancer Discovery is now online
Oncologist Near Me
Jan 16, 2025, 10:07
Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology
Blog
Jan 16, 2025, 10:01
Narjust Florez and Alfredo Addeo dive into the data from ESMO - IASLC
Insight
Jan 16, 2025, 09:56
N-Power Medicine Acquired Syapse to Enhance Oncology Research Network
Dialogues
Jan 16, 2025, 09:53
ColoSense: Advancing Noninvasive Colorectal Cancer Screening Through Innovative Diagnostics
Science
Jan 16, 2025, 09:48
Sarbajit Mukherjee: Excited to share my 50th publication from Roswell Park
Insight
Jan 16, 2025, 09:37
Laura Bukavina: Age doesn't limit EV efficacy